|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||4.75 / 28.56|
Phase IIa Clinical Data Presented at the ASCO 2016 Genitourinary Cancers Symposium
New Data Demonstrate Supinoxin™ Dose Dependently Inhibits Tumor Cell Growth in a Preclinical Model of Triple Negative Breast Cancer
Interim Data Show Archexin is Well Tolerated at the Doses Tested to Date With Early Evidence of Anti-Tumor Activity Observed in a Phase IIa Clinical Study in Metastatic Renal Cell Carcinoma
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Interim Data Suggest Potential Clinical Activity of Supinoxin™ and RX-3117 Anti-Cancer Therapies
Supinoxin(TM) and RX-3117 Are Safe and Well Tolerated in Cancer Patients With Advanced and Metastatic Solid Tumors and Demonstrate Preliminary Evidence of Clinical Activity
Presentations at Recent Scientific Conferences Showcase Novel Anti-Tumor Properties of Rexahn Compounds
Program Will Provide Foundation for Filing an IND Application for Phase I Trial
These under-$10 stocks look poised to breakout out and trade higher from current levels.
New Data on RX-3117 and Supinoxin(TM) Substantially Increase Excitement Around These Programs in Scientific and Clinical Oncology Communities
Data Presented at 2015 American Association for Cancer Research (AACR) Annual Meeting
RX-3117 Antitumor Activity Correlates With UCK2 Enzymatic Activity
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.